Luxembourg-based space technology company LUXSPACE Sàrl, a subsidiary of OHB Technology AG (ISIN: DE0005936124), is joining forces with the NGO Sant'Egidio, Rome, and the University of Padova to produce a study identifying ways in which space-based technologies can help to facilitate the logistic distribution of HIV/AIDS medicines in Africa. Financed by the European Space Agency, the study forms part of the “DREAM” (Drug Resource Enhancement against AIDS and Malnutrition) project, which the Community of Sant'Egidio has established.

In Africa in particular, where the infrastructure is frequently wanting, the regular and permanent provision of HIV/AIDS treatments constitutes a logistic challenge. In this study, the three partners are seeking to address these challenges. The approach they are taking is this: By employing space-based technologies such as satellite communications, the logistic distribution of medicines and the deployment of doctors is to be coordinated more effectively.

Of the various strategies in the war against HIV/AIDS, the antiretroviral therapy (ART) has proved to be an effective treatment. However, this therapy calls for the patient to take a cocktail of medicines each day and to undergo regular medical examinations and checkups. This is the only way of adjusting the medicines in accordance with the patient’s individual needs and ensuring the best possible treatment.
The study is to have a duration of one year.

LuxSpace is a Space System and Applications company, owned by OHB Technology AG of Bremen, Germany.


For more information, please contact:

Jochen Harms
General Manager
LUXSPACE Sarl
Chateau de Betzdorf
Building B
L-6815 Betzdorf
Luxembourg

Tel: 00352 267890 4021